UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000039172 |
|---|---|
| Receipt number | R000044601 |
| Scientific Title | Serum soluble (pro) renin receptor values and analysis in patients with solid cancer |
| Date of disclosure of the study information | 2020/03/01 |
| Last modified on | 2025/07/21 11:10:33 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Serum soluble (pro) renin receptor values and analysis in patients with solid cancer
Acronym
Serum soluble (pro) renin receptor values and analysis in patients with solid cancer
Scientific Title
Serum soluble (pro) renin receptor values and analysis in patients with solid cancer
Scientific Title:Acronym
Serum soluble (pro) renin receptor values and analysis in patients with solid cancer
Region
| Japan |
Condition
Condition
parients with solid cancer
Classification by specialty
| Medicine in general |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To investigate the characteristics of s(P)RR values in patients with solid cancer
Basic objectives2
Bio-availability
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Changes in s(P)RR values before and after cancer resection
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | < |
Age-upper limit
| 100 | years-old | > |
Gender
Male and Female
Key inclusion criteria
patients with solid cancer
Key exclusion criteria
patients who do not undergo cancer resection
Target sample size
200
Research contact person
Name of lead principal investigator
| 1st name | satoshi |
| Middle name | |
| Last name | morimoto |
Organization
tokyo Women's medical university
Division name
Department of Endocrinology and Hypertension
Zip code
166-8666
Address
8-1 Kawada-cho, Shinjuku-ku, Tokyo
TEL
03-3353-8111
morimoto.satoshi@twmu.ac.jp
Public contact
Name of contact person
| 1st name | yoshifumi |
| Middle name | |
| Last name | amari |
Organization
Moriguchi Keijinkai Hospital
Division name
Department of Nephrology
Zip code
570-0021
Address
2-47-12 Yagumohigashi-machi, Moriguchi-city, Osaka
TEL
06-6906-9000
Homepage URL
yoshifumi.0315@gmail.com
Sponsor or person
Institute
department of endocrinology and hypertension tokyo women's medical university
Institute
Department
Personal name
Funding Source
Organization
department of endocrinology and hypertension tokyo women's medical university
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Department of Endocrinology and Hypertension
Address
8-1 Kawada-cho, Shinjuku-ku, Tokyo
Tel
03-3353-8111
morimoto.satoshi@twmu.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2020 | Year | 03 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Terminated
Date of protocol fixation
| 2020 | Year | 01 | Month | 06 | Day |
Date of IRB
| 2020 | Year | 01 | Month | 15 | Day |
Anticipated trial start date
| 2020 | Year | 01 | Month | 15 | Day |
Last follow-up date
| 2021 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
none
Management information
Registered date
| 2020 | Year | 01 | Month | 16 | Day |
Last modified on
| 2025 | Year | 07 | Month | 21 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044601
